JAX donors contribute $100,000 to new COVID-19 models

JAX is fulfilling an urgent need for accurate animal models to test vaccines, neutralizing antibodies and other therapeutics against the SARS-CoV-2 virus to protect the global community against future COVID-19 pandemics. In humans, the virus enters cells by binding to ACE2, a cell surface protein that is slightly different in mice, which as a species, are not naturally susceptible to the disease.  JAX is currently distributing a mouse model called K18-hACE2, donated by its creators Stanley Perlman and Paul McCray, that overcomes this obstacle through the introduction of human ACE2 genes. The resulting transgenic mouse is highly susceptible to SARS-CoV-2 infection. The dissemination of the K18-haACE2 model by JAX is a huge step forward for pre-clinical testing of vaccines and antiviral drugs.

 Next-generation models for COVID-19 research

Thanks in part to recent gifts totaling $100,000 from supporters, JAX scientists will now develop innovative, more accurate mouse models for COVID-19 research that authentically mimic human responses to the viral life cycle. The new models will enable exploration of common and often lethal complications in COVID-19 patients with hypertension, diabetes or cardiovascular conditions. Read more

Related Posts

UNE receives $10.8 million to establish new Center for Cell Signaling Research

The University of New England has received a five-year, $10.8 million award from the National Institutes of Health to support an...

18 January 2024

Jackson Lab opens $4.5M on-site child care center in Bar Harbor

Anewly constructed child care center on the Jackson Laboratory’s Bar Harbor campus is seen as an important draw for employees that also...

17 January 2024

From med tech to skin care: Top Gun names 41 startups to 2024 lineup

Out of 57 companies that applied to Maine’s 2024 Top Gun business accelerator program, 41 have been accepted and will receive help...

16 January 2024